Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

NCT03527147

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site New Orleans, Louisiana, United States
View Trial Details
Completed

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

NCT01332968

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • The Regents of the University of California; Office of Research Irvine, California, United States
  • Kootenai Cancer Center Post Falls, Idaho, United States
  • Illinois Cancer Care, P.C. - Galesburg Galesburg, Illinois, United States
View all 183 locations
View Trial Details
Completed

A Study of PLX2853 in Advanced Malignancies.

NCT03297424

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +36 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine Miami, Florida, United States
  • Columbia University Medical Center New York, United States
  • South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States
View Trial Details
Completed

Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients

NCT02877550

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Universitaetsspital Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana Bellinzona, Switzerland
  • Inselspital, Bern Bern, Switzerland
  • Kantonsspital Graubünden Chur, Switzerland
View Trial Details
Completed

Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma

NCT03682796

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions